Status:
COMPLETED
Incidence and Predictors of Acute and Chronic Complications in Patients With Diabetes and Severe COVID-19
Lead Sponsor:
University of Michigan
Conditions:
Covid19
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
All surviving patients of the Michigan Medicine COVID-19 Cohort (M2C2, PI: Hayek) that were admitted to the University of Michigan for severe COVID-19 disease are eligible for this study. Investigator...
Detailed Description
Diabetic patients, particularly those with type 2 diabetes (T2D), are highly susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced adverse outcomes and complications. The...
Eligibility Criteria
Inclusion
- Inclusion Criteria • Have been diagnosed with COVID-19 and/or admitted with severe COVID19
- Exclusion Criteria
- • Women who are currently pregnant or breastfeeding
Exclusion
Key Trial Info
Start Date :
December 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05200819
Start Date
December 2 2020
End Date
February 20 2023
Last Update
December 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48105